Fichera Alessandro, Ragauskaite Laura, Silvestri Mark T, Elisseou Nicholas M, Rubin Michele A, Hurst Roger D, Michelassi Fabrizio
Department of Surgery, University of Chicago, Chicago, IL, USA.
J Gastrointest Surg. 2007 Dec;11(12):1647-52; discussion 1652-3. doi: 10.1007/s11605-007-0321-x. Epub 2007 Sep 29.
The anal transition zone (ATZ) after ileal pouch anal anastomosis (IPAA) for ulcerative colitis is considered at risk for dysplasia and persistent or recurrent disease activity. The long-term fate of the ATZ and the effects of histologic changes on defecatory function are not well-known.
To evaluate the inflammatory and preneoplastic changes of the ATZ in patients without preoperative dysplasia, yearly biopsies of the ATZ were obtained and functional results recorded on a questionnaire/diary. Histologic changes were correlated with simultaneous assessment of defecatory function.
Between 1992 and 2006, 225 patients underwent a stapled IPAA. A total of 238 successful biopsies of the ATZ were performed. There was no dysplasia found. Acute inflammation was noted in 4.6%, chronic inflammation in 84.9%, and normal mucosa in 10.5% of cases. Patients with chronic inflammation reported an average of 6.2+/-1.7 bowel movements/day and 93.2% of them were able to delay a bowel movement for at least 30 min. The presence of chronic ATZ inflammation did not seem to have a negative impact on function, with 96.1% of patients reporting perfect continence, and only 5.3% using protective pads.
Preservation of the ATZ in selected patients is safe and offers excellent long-term functional results. New onset dysplasia was not noted. Chronic inflammation had limited clinical impact. Presence of ATZ inflammation in a total of 89.5% of patients warrants life-long surveillance with biopsies.
溃疡性结肠炎患者行回肠储袋肛管吻合术(IPAA)后,肛管移行区(ATZ)被认为有发育异常及疾病持续或复发活动的风险。ATZ的长期转归以及组织学改变对排便功能的影响尚不清楚。
为评估术前无发育异常患者ATZ的炎症和癌前病变改变,每年对ATZ进行活检,并通过问卷/日记记录功能结果。将组织学改变与同时评估的排便功能进行关联分析。
1992年至2006年间,225例患者接受了吻合器IPAA手术。共对ATZ进行了238次成功活检。未发现发育异常。4.6%的病例有急性炎症,84.9%有慢性炎症,10.5%为正常黏膜。有慢性炎症的患者平均每天排便6.2±1.7次,其中93.2%的患者能够将排便推迟至少30分钟。慢性ATZ炎症似乎对功能没有负面影响,96.1%的患者报告控便良好,仅5.3%使用护垫。
在部分患者中保留ATZ是安全的,并能提供优异的长期功能结果。未发现新发发育异常。慢性炎症的临床影响有限。总计89.5%的患者存在ATZ炎症,因此需要通过活检进行终身监测。